VBIV
VBI Vaccines Inc
NASDAQ: VBIV · HEALTHCARE · BIOTECHNOLOGY
$0.07
+0.00% today
Updated 2026-04-30
Market cap
$1.87M
P/E ratio
—
P/S ratio
0.20x
EPS (TTM)
$-3.54
Dividend yield
—
52W range
$0 – $0
Volume
—
VBI Vaccines Inc (VBIV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-968.00%
ROE
-419.60%
ROA
-29.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2004 | — | $-51380.00 | — | — | — |
| 2005 | $79.00 | $-137070.00 | 100.00% | -173,506.33% | -173,506.33% |
| 2006 | — | $-343483.00 | — | — | — |
| 2007 | — | $-205286.00 | — | — | — |
| 2008 | — | $-558396.00 | — | — | — |
| 2009 | — | $-716982.00 | — | — | — |
| 2010 | — | $-716982.00 | — | — | — |
| 2011 | — | $-18.85M | — | — | — |
| 2012 | — | $-13.15M | — | — | — |
| 2013 | $-1.57M | $-6.65M | 295.75% | 453.99% | 424.31% |
| 2014 | $2.87M | $-65.92M | -28.97% | -160.69% | -2,298.59% |
| 2015 | $955000.00 | $-14.76M | -293.19% | -925.24% | -1,545.03% |
| 2016 | $548000.00 | $-23.20M | -569.89% | -4,534.67% | -4,234.49% |
| 2017 | $865000.00 | $-38.99M | -500.35% | -4,309.83% | -4,508.09% |
| 2018 | $3.35M | $-63.60M | -34.40% | -1,800.54% | -1,895.68% |
| 2019 | $2.22M | $-55.80M | -255.88% | -2,359.25% | -2,512.61% |
| 2020 | $1.06M | $-47.29M | -764.09% | -4,110.93% | -4,456.74% |
| 2021 | $631000.00 | $-72.65M | -1,606.81% | -10,781.62% | -11,513.47% |
| 2022 | $1.08M | $-140.95M | -942.14% | -7,561.92% | -13,026.89% |
| 2023 | $8.68M | $-92.84M | -66.98% | -637.08% | -1,069.29% |